|
May 8
|
AstraZeneca and Daiichi’s Enhertu shows pCR rate improvement in breast cancer trial
|
|
May 7
|
AstraZeneca (LSE:AZN) Reports Positive Phase 3 Trial Results For Breast Cancer Treatment
|
|
May 7
|
Q1 2025 Arcus Biosciences Inc Earnings Call
|
|
May 7
|
Expediting parallel drug approval pathways is challenging, but rewarding
|
|
May 7
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11
|
|
May 7
|
EC approves AstraZeneca’s Calquence combo to treat MCL
|
|
May 7
|
Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
|
|
May 6
|
AstraZeneca unveils new factory as part of multibillion-dollar investment in US manufacturing
|
|
May 6
|
AZN or ARGX: Which Is the Better Value Stock Right Now?
|
|
May 6
|
AstraZeneca's (LON:AZN) Earnings Offer More Than Meets The Eye
|
|
May 5
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Apr 15
|
Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 15
|
Tariff wars to hit popular US-made drugs in China, regulator data shows
|
|
Apr 14
|
Is AstraZeneca (AZN) The Best UK Stock to Buy According to Billionaires?
|
|
Apr 14
|
Nasdaq Bear Market: 3 Unstoppable Stocks You Can Buy With $300 Right Now
|
|
Apr 14
|
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
|
|
Apr 11
|
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More
|
|
Apr 11
|
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
|
|
Apr 10
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Apr 10
|
Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco
|